Webinars and Sponsored Roundtables — Register Now

Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.

Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications. 

Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.

Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

CAP Today Recommends

Grundium White Paper: How Compact, On-Demand Whole-Slide Imaging (WSI) Delivers High-Quality & Timely Diagnoses​

February 2026—Prepared with expert insight from Anil Parwani, MD, PhD; Scott Hammond; and Melinda Schumacher, MD, Grundium’s white paper describes, from a pathologist’s perspective, how compact WSI systems can shorten consult turnaround times and reduce variability, improve access to subspecialty review without adding travel or courier burden, enhance community pathologists’ professional satisfaction and confidence, support scalable, secure, and validated workflows and lay the foundation for AI and advanced analytics as digital adoption grows. Download the white paper here.

Seegene unveils CURECA–100% unattended PCR automation

Seegene introduced CURECA, a fully automated PCR solution that processes diverse specimen types (urine, blood, sputum, and stool) and performs the entire PCR workflow from sample loading to result. CURECA performs the entire PCR testing process without any human intervention, enabling nonstop operation, 24 hours a day, seven days a week. CURECA automatically stops and refills consumables and transfers testing plates to the next step. CURECA configuration can be tailored to specific laboratories that demand particular test types and have space constraints. CURECA offers flexibility in diagnostics, from small-scale to large-scale testing, enabling broad coverage of diseases.

The future of clinical laboratories in value-based care—Is this our tomorrow to lose?

April 2025—Many look to CAP TODAY to be a central disseminator of news, opinion, and other important information, and it has in the past filled that role in response to others’ requests. One such recent request is that of the Clinical Lab 2.0 movement, established in 2017 by the Project Santa Fe Foundation. We present here, for CAP TODAY readers, the Clinical Lab 2.0 movement’s position paper.

Revolutionizing cancer diagnosis: the game-changing role of digital pathology and artificial intelligence

Pathology plays a critical role in cancer care, encompassing the development of new treatments, diagnosis, staging, grading of disease, and clinical decision-making. While histopathological slides of tissue biopsies using hematoxylin and eosin staining and immunohistochemical staining remain central to this process, the rise of precision medicine testing is placing greater demands on pathology labs. Health care organizations globally are grappling with ways to address these challenges, mainly due to the declining number of individuals choosing pathology as a specialty.

Pathology Visions 2024—Decision Digital

The Digital Pathology Association (DPA) invites you to attend this year’s annual meeting, taking place Nov. 3–5 in Orlando, Fla. The theme for Pathology Visions 2024 is “Decision Digital.” Pathology Visions brings together hundreds of pioneers and peers across the field of digital pathology and AI. If you are a clinician, scientist, technician, or trainee, #PathVisions24 is the place for you. “Pathology Visions 2024 promises to be the highlight of the year and an event you won’t want to miss. We have brought together a diverse lineup of speakers who are leaders in their fields, ready to share their insights and breakthroughs.

Clinical Lab 2.0 honors laboratory team excellence

Clinical Lab 2.0, a Project Santa Fe Foundation initiative, released a proclamation during Medical Laboratory Professionals Week, April 14–20, to recognize and celebrate the roles of laboratory medicine and pathology in the field of medicine “as we transition from the business of volume to the business of value” in the delivery of integrated health care. Read the full proclamation here. Clinical Lab 2.0 was established to provide thought leadership and help develop the evidence base for the valuation of clinical

Xifin white paper: a guide to molecular Dx market-share expansion

Xifin released a white paper titled “The Executive’s Guide to Molecular Diagnostic Market-Share Expansion: Critical Success Factors for Maximizing Revenue, Patient Access, and Physician Engagement.” Authors Kyle Fetter, chief operating officer, and Harley Ross, chief commercial officer, offer practical approaches, process enhancements, and payor strategies essential to growing novel diagnostic market share through proactive, purposeful, and technologically enabled engagements with patients, physicians, and payors. Download the white paper here.

 

Amplify the value of your AP LIS

Now available from NovoPath and PathAI is a free webinar that aims to help viewers understand how digital pathology and AI can help an organization. Speakers Eric Walk, MD, Jim Sweeney, and R. Shawn Kinsey, MD, from PathAI and Ed Youssef from NovoPath discuss how digital pathology and AI can streamline your pathology workflows and how some of the largest labs in the United States are already applying these applications. The webinar, titled “Digital pathology and artificial intelligence 101: unlocking value from the AP LIS,” is available through the link here. Registration is required to access the webinar.

Pathology Visions 2023

“Igniting Digital Pathology Transformation”—the theme for Pathology Visions 2023. The Digital Pathology Association (DPA) invites you to attend this year’s annual meeting taking place October 29–31 in Orlando, Fla. Pathology Visions brings together hundreds of pioneers and peers across the field of digital pathology to address real-world, practical applications of digital pathology and AI today, as well as the future. Attendees have access to more than 50 expert presenters, over 70 poster presentations, nearly 50 vendors showcasing the latest innovations, countless opportunities for discussion and engagement, and much more. If you are a clinician, scientist, technician, or trainee #PathVisions23 is the place for you.

Dark Daily to present free webinar on
Z-Code application process

UnitedHealthcare is requiring, effective Aug. 1, that genetic test claims associated with about 250 CPT codes include a Z-Code issued by the MolDx Diagnostic Exchange (DEX) registry, operated by Palmetto GBA, a Medicare administrative contractor. To help clinical labs meet their needs for swift Z-Code registration of their genetic tests, the Dark Report and Dark Daily are presenting a free, 90-minute webinar titled “Essential Guide to Obtaining Z-Codes for Molecular and Genetic Tests” on Thursday, June 29, at 1 pm EDT. The keynote speaker is Gabriel Bien-Willner, MD, PhD, chief medical officer of Palmetto GBA and medical director of the Molecular Diagnostic Services Program (MolDx). He will provide an up-to-the-minute picture of the DEX MolDx Z-Code registry, including the application and documentation processes needed to register a molecular test and obtain a unique Z-Code for that test.